These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39168026)

  • 1. Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program.
    Cai SR; Huang YQ; Li QR; Zhu HH; Zhang SZ; Song YM; Yang JH; Zheng S
    ESMO Open; 2024 Sep; 9(9):103676. PubMed ID: 39168026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
    Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.
    Cai SR; Huang YQ; Zhang SZ; Li QR; Ma XY; Zheng S
    BMC Cancer; 2019 Jan; 19(1):47. PubMed ID: 30630450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening.
    Cai SR; Zhu HH; Huang YQ; Li QL; Ma XY; Zhang SZ; Zheng S
    Biomed Res Int; 2016; 2016():6830713. PubMed ID: 27144171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
    Liao Y; Li S; Chen C; He X; Lin F; Wang J; Yang Z; Lan P
    Gastroenterol Rep (Oxf); 2018 May; 6(2):132-136. PubMed ID: 29780602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China.
    Lin G; Feng Z; Liu H; Li Y; Nie Y; Liang Y; Li K
    Sci Rep; 2019 Jul; 9(1):10424. PubMed ID: 31320661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
    Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment.
    Ishibashi F; Suzuki S; Kobayashi K; Tanaka R; Kawakami T; Mochida K; Nagai M; Ishibashi Y; Morishita T
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1328-1335. PubMed ID: 38348570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results.
    Zhou Q; Li HL; Li Y; Gu YT; Liang YR; Liu HZ; Li K; Dong H; Chen YY; Lin GZ
    BMJ Open; 2021 Sep; 11(9):e049581. PubMed ID: 34489283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
    Yuan Z; Wang S; Wang Y; Li H; Gao W; Liu X; Han Y; Liu Z; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
    BMC Gastroenterol; 2023 Dec; 23(1):435. PubMed ID: 38087194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.
    Wong MC; Ching JY; Chan VC; Sung JJ
    Sci Rep; 2015 Sep; 5():13568. PubMed ID: 26338314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
    Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.
    Li JB; Qiu ZY; Deng YX; Li Y; Lin ZC; Wu YP; Weng F; Tian H; Ou QJ; Gong CH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Discov Oncol; 2022 Jan; 13(1):4. PubMed ID: 35201502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.